Avid Bioservices Inc (CDMO)

[vinmantoo]

AbbVie and Bristol-Myers Squibb Announce Oncology Clinical Collaboration to Evaluate the Combination of Rova-T plus Opdivo and Opdivo + Yervoy Regimen- Collaboration will explore the safety and potential enhanced efficacy of combining checkpoint inhibitors with a cancer stem cell-targeting antibody drug conjugate in SCLC- Expect to begin patient enrollment in 2016

Well, what do you know, I hit that one on the head with my predictions and comments on combinations with IO using growth inhibitors or antibody drug conjugates to cancer cell markers. I own both SGEN and IMGN. I didn't have much of the latter as I sold off most of it when their Herceptin Ab drug conjugate didn't expand its usage, but recently bought a nice chunk at $3.13. I will buy more again, probably this week as it is now around $2.80.

You know Garnick is feeling happier than usual today given his role with Rova-T development.